SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders. La présente invention concerne des formulations...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YELESWARAM, KRISHNASWAMY, NI, YONG, PARIKH, BHAVNISH, ERICKSON-VIITANEN, SUSAN, WILLIAMS, WILLIAM V
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders. La présente invention concerne des formulations et des formes galéniques à libération prolongée du ruxolitinib, ou d'un sel pharmaceutiquement acceptable de celui-ci, qui peuvent être utilisées dans le cadre du traitement de maladies associées à la Janus kinase, tels que les troubles myéloprolifératifs.